GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » Total Stockholders Equity

Dai Han Pharmaceutical Co (XKRX:023910) Total Stockholders Equity : ₩251,831 Mil (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co Total Stockholders Equity?

Dai Han Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩251,831 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Dai Han Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ₩42,828.33. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Dai Han Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.


Dai Han Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Dai Han Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co Total Stockholders Equity Chart

Dai Han Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 166,775.26 181,923.45 202,808.02 225,398.09 247,974.09

Dai Han Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 228,885.37 236,251.10 244,107.96 247,974.09 251,830.57

Dai Han Pharmaceutical Co  (XKRX:023910) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Dai Han Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Dai Han Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dai Han Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Dai Han Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Dai Han Pharmaceutical Co (XKRX:023910) Business Description

Traded in Other Exchanges
N/A
Address
8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR
Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co (XKRX:023910) Headlines

No Headlines